- Home
- OCFT vs ALGS Comparison
OCFT vs ALGS Comparison
Compare OCFT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- ALGS
- Stock Information
- Founded
- OCFT 2015
- ALGS 2018
- Country
- OCFT China
- ALGS United States
- Employees
- OCFT N/A
- ALGS N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- OCFT Technology
- ALGS Health Care
- Exchange
- OCFT Nasdaq
- ALGS Nasdaq
- Market Cap
- OCFT 102.5M
- ALGS 118.8M
- IPO Year
- OCFT 2019
- ALGS 2020
- Fundamental
- Price
- OCFT $2.86
- ALGS $34.24
- Analyst Decision
- OCFT Strong Buy
- ALGS Strong Buy
- Analyst Count
- OCFT 1
- ALGS 1
- Target Price
- OCFT $7.00
- ALGS $75.00
- AVG Volume (30 Days)
- OCFT 20.2K
- ALGS 435.1K
- Earning Date
- OCFT 03-17-2025
- ALGS 03-11-2025
- Dividend Yield
- OCFT N/A
- ALGS N/A
- EPS Growth
- OCFT N/A
- ALGS N/A
- EPS
- OCFT 0.00
- ALGS N/A
- Revenue
- OCFT $407,825,504.00
- ALGS $5,997,000.00
- Revenue This Year
- OCFT N/A
- ALGS N/A
- Revenue Next Year
- OCFT N/A
- ALGS N/A
- P/E Ratio
- OCFT $28.09
- ALGS N/A
- Revenue Growth
- OCFT N/A
- ALGS N/A
- 52 Week Low
- OCFT $0.87
- ALGS $6.76
- 52 Week High
- OCFT $4.98
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- OCFT 61.77
- ALGS 50.11
- Support Level
- OCFT $2.41
- ALGS $30.31
- Resistance Level
- OCFT $2.80
- ALGS $35.30
- Average True Range (ATR)
- OCFT 0.15
- ALGS 4.64
- MACD
- OCFT 0.03
- ALGS -1.68
- Stochastic Oscillator
- OCFT 93.24
- ALGS 32.83
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.